Nordic BioVentures ApS — Credit Rating and Financial Key Figures
CVR number: 43852116
Sankt Knuds Vej 22 C, 1903 Frederiksberg C
josephine@nordicbioventures.com
tel: 22627767
https://www.arc-arrow.com/
Income statement (kDKK)
2023 | 2024 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 3 262.92 | 2 381.89 |
| Employee benefit expenses | -1 367.51 | -2 004.03 |
| EBIT | 1 882.54 | 377.86 |
| Other financial income | 10.07 | 3.18 |
| Other financial expenses | 12.88 | -33.30 |
| Pre-tax profit | 1 892.61 | 347.75 |
| Income taxes | - 422.00 | -81.77 |
| Net earnings | 1 470.61 | 265.97 |
Assets (kDKK)
2023 | 2024 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Participating interests | 670.00 | 1 420.00 |
| Investments total | 670.00 | 1 420.00 |
| Long term receivables total | ||
| Inventories total | ||
| Current trade debtors | 32.38 | 32.27 |
| Current other receivables | 881.01 | 135.69 |
| Short term receivables total | 913.39 | 167.96 |
| Cash and bank deposits | 518.30 | 491.99 |
| Cash and cash equivalents | 518.30 | 491.99 |
| Balance sheet total (assets) | 2 101.69 | 2 079.95 |
Equity and liabilities (kDKK)
2023 | 2024 | |
|---|---|---|
| Share capital | 40.00 | |
| Retained earnings | 1 430.61 | |
| Profit of the financial year | 1 470.61 | 265.97 |
| Shareholders equity total | 1 470.61 | 1 736.58 |
| Non-current liabilities total | ||
| Current trade creditors | 19.64 | 10.00 |
| Current owed to participating | 0.40 | |
| Short-term deferred tax liabilities | 422.00 | 81.77 |
| Other non-interest bearing current liabilities | 189.04 | 251.59 |
| Current liabilities total | 631.08 | 343.37 |
| Balance sheet total (liabilities) | 2 101.69 | 2 079.95 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.